These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 30378066)
41. The Extract of Han YH; Mun JG; Jeon HD; Yoon DH; Choi BM; Kee JY; Hong SH Nutrients; 2020 Oct; 12(10):. PubMed ID: 33086629 [TBL] [Abstract][Full Text] [Related]
42. Activated mast cells in skeletal muscle can be a potential mediator for cancer-associated cachexia. Widner DB; Liu C; Zhao Q; Sharp S; Eber MR; Park SH; Files DC; Shiozawa Y J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):1079-1097. PubMed ID: 34008339 [TBL] [Abstract][Full Text] [Related]
44. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice. Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608 [TBL] [Abstract][Full Text] [Related]
45. Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readouts. Jourdain M; Melly S; Summermatter S; Hatakeyama S Biochem Biophys Res Commun; 2018 Sep; 503(4):2415-2420. PubMed ID: 29969629 [TBL] [Abstract][Full Text] [Related]
46. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia. Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770 [TBL] [Abstract][Full Text] [Related]
47. Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling. Straughn AR; Kakar SS J Ovarian Res; 2019 Nov; 12(1):115. PubMed ID: 31767036 [TBL] [Abstract][Full Text] [Related]
48. Displaced Myonuclei in Cancer Cachexia Suggest Altered Innervation. Daou N; Hassani M; Matos E; De Castro GS; Costa RGF; Seelaender M; Moresi V; Rocchi M; Adamo S; Li Z; Agbulut O; Coletti D Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041358 [TBL] [Abstract][Full Text] [Related]
49. Pentraxin 3 is an adipose tissue-related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss. Sato K; Hikita H; Shigekawa M; Kato S; Sasaki Y; Shinkai K; Fukuoka M; Kudo S; Sato Y; Fukumoto K; Shirai K; Myojin Y; Sakane S; Murai K; Yoshioka T; Nishio A; Kodama T; Sakamori R; Tatsumi T; Takehara T Cancer Sci; 2022 Dec; 113(12):4311-4326. PubMed ID: 36074525 [TBL] [Abstract][Full Text] [Related]
50. Effects of the beta Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866 [TBL] [Abstract][Full Text] [Related]
51. Effects of S-pindolol in mouse pancreatic and lung cancer cachexia models. Springer J; Jové Q; de Lima Junior EA; Ladrón NÁ; López-Soriano FJ; Busquets S; Argiles JM; Marks DL J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1244-1248. PubMed ID: 37130578 [TBL] [Abstract][Full Text] [Related]
52. Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know? Dolly A; Dumas JF; Servais S J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1413-1428. PubMed ID: 33053604 [TBL] [Abstract][Full Text] [Related]
53. Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia. Deng M; Cao J; van der Kroft G; van Dijk DPJ; Aberle MR; Grgic A; Neumann UP; Wiltberger G; Balluff B; Schaap FG; Heeren RMA; Olde Damink SWM; Rensen SS J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1283-1297. PubMed ID: 38725139 [TBL] [Abstract][Full Text] [Related]
54. Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting. Huang XY; Huang ZL; Yang JH; Xu YH; Sun JS; Zheng Q; Wei C; Song W; Yuan Z J Exp Clin Cancer Res; 2016 Mar; 35():46. PubMed ID: 26975989 [TBL] [Abstract][Full Text] [Related]
55. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice. Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218 [TBL] [Abstract][Full Text] [Related]
57. Motor protein function in skeletal abdominal muscle of cachectic cancer patients. Taskin S; Stumpf VI; Bachmann J; Weber C; Martignoni ME; Friedrich O J Cell Mol Med; 2014 Jan; 18(1):69-79. PubMed ID: 24251822 [TBL] [Abstract][Full Text] [Related]
58. Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities. Talbert EE; Yang J; Mace TA; Farren MR; Farris AB; Young GS; Elnaggar O; Che Z; Timmers CD; Rajasekera P; Maskarinec JM; Bloomston M; Bekaii-Saab T; Guttridge DC; Lesinski GB Mol Cancer Ther; 2017 Feb; 16(2):344-356. PubMed ID: 27811010 [TBL] [Abstract][Full Text] [Related]
59. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia. Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031 [TBL] [Abstract][Full Text] [Related]
60. Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia. Marchildon F; Lamarche É; Lala-Tabbert N; St-Louis C; Wiper-Bergeron N PLoS One; 2015; 10(12):e0145583. PubMed ID: 26709824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]